203 related articles for article (PubMed ID: 27518127)
1. KSHV non-structural membrane proteins involved in the activation of intracellular signaling pathways and the pathogenesis of Kaposi's sarcoma.
Abere B; Schulz TF
Curr Opin Virol; 2016 Oct; 20():11-19. PubMed ID: 27518127
[TBL] [Abstract][Full Text] [Related]
2. Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication.
Abere B; Samarina N; Gramolelli S; Rückert J; Gerold G; Pich A; Schulz TF
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950425
[TBL] [Abstract][Full Text] [Related]
3. The Kaposi's sarcoma-associated herpesvirus (KSHV) non-structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target.
Abere B; Mamo TM; Hartmann S; Samarina N; Hage E; Rückert J; Hotop SK; Büsche G; Schulz TF
PLoS Pathog; 2017 Sep; 13(9):e1006639. PubMed ID: 28938025
[TBL] [Abstract][Full Text] [Related]
4. Initiation of angiogenic Kaposi's sarcoma lesions.
Hayward GS
Cancer Cell; 2003 Jan; 3(1):1-3. PubMed ID: 12559168
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma herpesvirus-induced endothelial cell reprogramming supports viral persistence and contributes to Kaposi's sarcoma tumorigenesis.
Gramolelli S; Ojala PM
Curr Opin Virol; 2017 Oct; 26():156-162. PubMed ID: 29031103
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma herpesvirus K15 protein contributes to virus-induced angiogenesis by recruiting PLCγ1 and activating NFAT1-dependent RCAN1 expression.
Bala K; Bosco R; Gramolelli S; Haas DA; Kati S; Pietrek M; Hävemeier A; Yakushko Y; Singh VV; Dittrich-Breiholz O; Kracht M; Schulz TF
PLoS Pathog; 2012 Sep; 8(9):e1002927. PubMed ID: 23028325
[TBL] [Abstract][Full Text] [Related]
7. Kaposi's sarcoma virally encoded, G-protein-coupled receptor: a paradigm for paracrine transformation.
Martin D; Gutkind JS
Methods Enzymol; 2009; 460():125-50. PubMed ID: 19446723
[TBL] [Abstract][Full Text] [Related]
8. KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma.
Ma T; Patel H; Babapoor-Farrokhran S; Franklin R; Semenza GL; Sodhi A; Montaner S
Angiogenesis; 2015 Oct; 18(4):477-88. PubMed ID: 26092770
[TBL] [Abstract][Full Text] [Related]
9. Biology of Kaposi's sarcoma-associated herpesvirus.
Bryan BA; Dyson OF; McCubrey JA; Akula SM
Front Biosci; 2005 Sep; 10():2882-91. PubMed ID: 15970542
[TBL] [Abstract][Full Text] [Related]
10. CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-κB activation.
Hunte R; Alonso P; Thomas R; Bazile CA; Ramos JC; van der Weyden L; Dominguez-Bendala J; Khan WN; Shembade N
PLoS Pathog; 2018 Apr; 14(4):e1006968. PubMed ID: 29698475
[TBL] [Abstract][Full Text] [Related]
11. Glycosylation of KSHV encoded vGPCR functions in its signaling and tumorigenicity.
Wu H; Liu L; Xiao J; Chi M; Qu Y; Feng H
Viruses; 2015 Mar; 7(4):1627-41. PubMed ID: 25835533
[TBL] [Abstract][Full Text] [Related]
12. Cellular origin of Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus-induced cell reprogramming.
Cancian L; Hansen A; Boshoff C
Trends Cell Biol; 2013 Sep; 23(9):421-32. PubMed ID: 23685018
[TBL] [Abstract][Full Text] [Related]
13. Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes.
Montaner S; Sodhi A; Molinolo A; Bugge TH; Sawai ET; He Y; Li Y; Ray PE; Gutkind JS
Cancer Cell; 2003 Jan; 3(1):23-36. PubMed ID: 12559173
[TBL] [Abstract][Full Text] [Related]
14. An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia.
Martin D; Galisteo R; Ji Y; Montaner S; Gutkind JS
Oncogene; 2008 Mar; 27(13):1844-52. PubMed ID: 17934524
[TBL] [Abstract][Full Text] [Related]
15. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.
Bais C; Santomasso B; Coso O; Arvanitakis L; Raaka EG; Gutkind JS; Asch AS; Cesarman E; Gershengorn MC; Mesri EA
Nature; 1998 Jan; 391(6662):86-9. PubMed ID: 9422510
[TBL] [Abstract][Full Text] [Related]
16. Emerging targets and novel strategies in the treatment of AIDS-related Kaposi's sarcoma: bidirectional translational science.
Dezube BJ; Sullivan R; Koon HB
J Cell Physiol; 2006 Dec; 209(3):659-62. PubMed ID: 17001705
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma-associated herpesvirus vFLIP promotes MEndT to generate hybrid M/E state for tumorigenesis.
Chen W; Ding Y; Liu D; Lu Z; Wang Y; Yuan Y
PLoS Pathog; 2021 Dec; 17(12):e1009600. PubMed ID: 34936683
[TBL] [Abstract][Full Text] [Related]
18. KSHV-induced ligand mediated activation of PDGF receptor-alpha drives Kaposi's sarcomagenesis.
Cavallin LE; Ma Q; Naipauer J; Gupta S; Kurian M; Locatelli P; Romanelli P; Nadji M; Goldschmidt-Clermont PJ; Mesri EA
PLoS Pathog; 2018 Jul; 14(7):e1007175. PubMed ID: 29985958
[TBL] [Abstract][Full Text] [Related]
19. Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis?
Sodhi A; Montaner S; Gutkind JS
FASEB J; 2004 Mar; 18(3):422-7. PubMed ID: 15003988
[TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis.
Viejo-Borbolla A; Schulz TF
AIDS Rev; 2003; 5(4):222-9. PubMed ID: 15012001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
